Explainer

Mood Disorder Questionnaire (MDQ): Questions, Scoring, Accuracy

The Mood Disorder Questionnaire screens for past mania with 13 yes/no items. A 2015 meta-analysis of 21 studies found it caught 62% of bipolar cases.

Mental Health Stats Research Team 8 min read

Key Takeaways

  • The Mood Disorder Questionnaire (MDQ) is a self-report screen with 13 yes/no symptom items plus questions on symptom clustering and impairment, takes less than 5 minutes, and is designed for screening only[1].13 items[1]
  • A standard positive screen needs 7 or more yes answers, symptoms in the same period, and a moderate or serious problem; the cutoff of 7 gave 0.73 sensitivity and 0.90 specificity in the 2000 validation study[1][2].7 of 13[2]
  • A 2015 meta-analysis of 21 studies found a pooled sensitivity of 0.62 and specificity of 0.85, but sensitivity fell to 0.37 in depressed patients with no known bipolar diagnosis[3].62%[3]
  • Across studies reviewed in 2011, the MDQ detected 66.3% of bipolar I cases but only 38.6% of bipolar II cases[4].38.6%[4]
  • Dropping the impairment requirement raised sensitivity from 63.5% to 75.0% among 480 psychiatric outpatients in 2009, while specificity fell from 84.8% to 78.5%[5].75.0%[5]
  • The parent-report adolescent version (MDQ-A) at 5 or more items had 0.72 sensitivity and 0.81 specificity in 104 adolescent outpatients, 2006[6].72%[6]
How to read MDQ accuracy figures: validation studies compare MDQ results with a structured diagnostic interview, most often the Structured Clinical Interview for DSM-IV (SCID)[2][5]. Sensitivity is the share of people with bipolar disorder who screen positive and specificity is the share without it who screen negative. Positive predictive value is the share of positive screens that turn out to be bipolar disorder, and it drops when the disorder is uncommon in the group screened.

What Is the Mood Disorder Questionnaire?

The Mood Disorder Questionnaire (MDQ) is a one-page self-report screen for bipolar disorder that asks whether a person has ever had a period of manic or hypomanic symptoms. It was published in the American Journal of Psychiatry in 2000 by Robert Hirschfeld and colleagues, who drew its 13 yes/no items from DSM-IV criteria and clinical experience[2].

It is one of several short questionnaires clinics use to flag possible mental illness for a fuller assessment. The form states that it takes less than 5 minutes and is "designed for screening purposes only and is not to be used as a diagnostic tool"[1].

The MDQ targets bipolar spectrum disorders and screens for a lifetime history of a manic or hypomanic syndrome, not for current mood[2]. A person who is depressed today can still screen positive if earlier episodes fit the pattern.

Two of its questions still use the older term "manic-depressive illness"[1]. NIMH notes that this was the former name for bipolar disorder[7].

Bipolar spectrum disorder

The group of conditions the MDQ was built to detect: bipolar I disorder, bipolar II disorder and bipolar disorder not otherwise specified[2]. NIMH describes bipolar disorder as a mental illness that causes clear shifts in mood, energy, activity levels and concentration, with manic episodes of elated, irritable or energized behavior and depressive episodes[7].

Related Terms

bipolar I disorder
bipolar II disorder
hypomania
manic episode

Source: Hirschfeld et al., American Journal of Psychiatry (2000); NIMH (2024)

The MDQ Questions: What Each Part Asks

Question 1 opens with "Has there ever been a period of time when you were not your usual self and..." and lists 13 experiences, each answered yes or no[1]. The items cover elevated or irritable mood, self-confidence, sleep, speech, racing thoughts, distractibility, energy, activity, sociability, sex drive, risk-taking and spending[1].

Four shorter questions follow[1]:

  • Question 2 asks whether several of the checked experiences happened during the same period of time.
  • Question 3 asks how much of a problem they caused, such as trouble working, family, money or legal troubles, or fights, rated as no, minor, moderate or serious problem.
  • Question 4 asks whether any blood relative has had manic-depressive illness or bipolar disorder.
  • Question 5 asks whether a health professional has ever said the person has manic-depressive illness or bipolar disorder.

Question 2 checks whether symptoms co-occurred and question 3 rates functional impairment, and the scoring rule uses both[1]. That is what separates the MDQ from a plain checklist of mania symptoms.

MDQ Question 1: The 13 Symptom Items

ItemAsks about a time when the person...Symptom area
1Felt so good or hyper that others noticed, or got into troubleElevated mood
2Was so irritable they shouted or started fightsIrritability
3Felt much more self-confident than usualSelf-confidence
4Slept much less and did not miss itLess need for sleep
5Was much more talkative or spoke fasterSpeech
6Had thoughts racing or could not slow the mindRacing thoughts
7Was so distracted they could not stay on trackDistractibility
8Had much more energy than usualEnergy
9Was much more active or did many more thingsActivity
10Was much more social, such as calling friends at nightSociability
11Was much more interested in sexSex drive
12Did unusual, excessive, foolish or risky thingsRisk-taking
13Spent money in a way that caused troubleSpending

Paraphrased wording of the 13 yes/no items in MDQ question 1, from the standard adult form[1].

1Yes answers are summed into a symptom count from 0 to 13; questions 2 to 5 are not part of that count[1][6].

Sources

  • •OHSU MDQ form, 2019

How to Score the Mood Disorder Questionnaire

Under the standard rule, a screen is positive only when all three conditions are met[1]:

  1. Yes to 7 or more of the 13 items in question 1[1].
  2. Yes to question 2, meaning several symptoms happened in the same period.
  3. "Moderate problem" or "serious problem" on question 3.

Questions 4 and 5, on family history and past diagnosis, are not part of the scoring rule[1]. The form directs a physician, nurse or medical staff assistant to score it after the patient completes it[1].

The cutoff of 7 comes from the original validation[2]. Of 198 patients at five outpatient clinics that mainly treat mood disorders, 109 (55%) received a bipolar spectrum diagnosis in a blind telephone SCID interview[2].

At 7 or more items, the MDQ had a sensitivity of 0.73 and a specificity of 0.90[2]. Higher cutoffs lost sensitivity without a clear gain in specificity, and lower cutoffs cost considerable specificity[2].

Put another way, about 7 in 10 people with a bipolar spectrum disorder in those clinics screened positive, and 9 in 10 without one screened negative[2].

Alternative MDQ Scoring Rules

Several studies have tested what happens when the impairment requirement in question 3 is relaxed[5][8]. In a Rhode Island study of 480 psychiatric outpatients, 52 (10.4%) of whom had bipolar disorder, standard scoring caught 63.5% of bipolar cases[5].

When moderate or serious impairment was not required, sensitivity rose to 75.0% and specificity fell from 84.8% to 78.5%[5]. The authors concluded that standard scoring gave inadequate sensitivity in that setting[5].

A French validation found the same pattern for bipolar II disorder. Standard scoring identified 52.4% of patients with bipolar II, and lowering the level of impairment required raised that to 76.2%[8].

A 2011 review of nearly two dozen MDQ reports found that lowering the threshold markedly improved sensitivity with only a modest loss of specificity[4]. Studies searching for the single best symptom cutoff, however, produced inconsistent results[4].

A 2015 meta-analysis suggested that the cutoff be adjusted to raise sensitivity when the MDQ is used with depressed patients who have no previous bipolar diagnosis[3]. The adolescent version uses a lower threshold of 5 items on the parent-report form[6].

MDQ Accuracy by Scoring Rule and Sample

StudySampleScoringSensitivitySpecificity
Hirschfeld, 2000198 mood-clinic outpatientsStandard (7+)73%90%
Zimmerman, 2009480 psychiatric outpatientsStandard (7+)63.5%84.8%
Zimmerman, 2009480 psychiatric outpatientsNo impairment required75.0%78.5%
Weber Rouget, 200596 mood-disorder outpatients, FranceStandard (7+)74.1%90.5%
Weber Rouget, 2005Bipolar II patients onlyStandard (7+)52.4%n/r
Weber Rouget, 2005Bipolar II patients onlyLower impairment level76.2%n/r
Hirschfeld, 2005Primary care adults on antidepressantsStandard (7+)58%93%
Hirschfeld, 2003695 U.S. adults, general populationStandard (7+)28.1%97.2%
Wagner, 2006104 adolescents, parent report5+ items (MDQ-A)72%81%

Sensitivity and specificity of the MDQ against structured diagnostic interviews, by scoring rule and setting[2][5][8][9][10][6].

1n/r: specificity was not reported separately for the bipolar II subgroup[8].

2Adult studies used the SCID as the reference standard; the adolescent study used the K-SADS-PL interview[2][6].

3Values reported as proportions (for example, 0.73) are shown as percentages.

Sources

  • •Hirschfeld et al., 2000, 2003, 2005
  • •Zimmerman et al., 2009
  • •Weber Rouget et al., 2005
  • •Wagner et al., 2006

How Accurate Is the Mood Disorder Questionnaire?

Pooling 21 studies, a 2015 meta-analysis in Depression and Anxiety found a summary sensitivity of 0.62 and specificity of 0.85 at a cutoff of 7[3]. In the 11 studies that included both patients with bipolar disorder and patients with unipolar depression, sensitivity was 0.76 and specificity 0.81[3].

The weak spot is the group screening is meant to help. In 6 studies that excluded patients already known to have bipolar disorder, sensitivity fell to 0.37, with specificity of 0.88[3].

Subtype matters as much as setting. Across studies in the 2011 review, the MDQ detected 66.3% of bipolar I cases but 38.6% of bipolar II cases[4]. The French validation showed the same gap, 90.3% for bipolar I against 52.4% for bipolar II[8].

In a U.S. general population sample of 695 adults interviewed by telephone, the MDQ flagged 28.1% of those with bipolar I or II disorder and correctly cleared 97.2% of those without it[10]. The authors argued that the diagnostic interview's limited reliability in community samples meant measured sensitivity could not exceed about 0.4[10].

For a side-by-side look at other bipolar screens and online quizzes, see the bipolar test overview.

MDQ sensitivity in studies that excluded patients with a known bipolar diagnosis (6 studies, 2015 meta-analysis)
37%

Across all 21 studies the MDQ caught 62% of bipolar cases. Among patients not already diagnosed, the group a screen is meant to find, it caught just over a third.

"the summary sensitivity was significantly reduced to .37 and summary specificity was .88"

Depression and Anxiety (Wang et al.)(2015) View Source

MDQ Reliability and Translated Versions

The original English MDQ had a Cronbach's alpha of 0.90, a measure of how consistently its items track the same construct[2]. The French translation reached 0.89[8].

When French patients repeated the questionnaire a month later, agreement was a kappa of 0.79, with similar stability for bipolar I (0.75) and bipolar II (0.77)[8].

The 2015 meta-analysis found no significant difference in accuracy between studies from Eastern and Western countries after adjusting for clinical differences between samples[3].

MDQ vs. HCL-32 and the Adolescent MDQ-A

The 32-item Hypomania Checklist (HCL-32) is another self-report screen for bipolar disorder[11]. A 2019 meta-analysis pooled 9 studies in which the same patients completed both questionnaires[11].

Sensitivity was similar, 82% for the HCL-32 and 80% for the MDQ, but the MDQ had higher specificity, 70% against 57%[11]. In those studies, the HCL-32 caught a similar share of cases while flagging more people who did not have bipolar disorder[11].

The authors concluded that both tools have acceptable psychometric properties for identifying bipolar disorder[11].

The adolescent version (MDQ-A)

The MDQ-A adapts the questionnaire for adolescents and has self-report and parent-report forms. In a 2006 study of 104 adolescent psychiatric outpatients and their parents, the parent form at 5 or more items had a sensitivity of 0.72 and specificity of 0.81, better than the adolescent self-report[6].

What MDQ Results Mean in Practice

A positive MDQ means bipolar disorder is worth assessing, not that it is present. In the Rhode Island outpatient study, 33.7% of positive screens had bipolar disorder under standard scoring, and 29.8% when impairment was not required[5].

A negative screen was more informative in that sample: negative predictive value was 95.0% under standard scoring and 96.3% without the impairment requirement[5]. Predictive values depend on how common the disorder is in the group screened, and 10.4% of that sample had bipolar disorder[5].

The case for screening rests on missed diagnoses. In a University of Texas family medicine clinic, 21.3% of adults taking an antidepressant for depression screened positive, and nearly two thirds of them had never received a bipolar diagnosis[9].

Evidence on whether screening improves outcomes is thin and dated. A 2011 review concluded that routine clinical use of the MDQ could not be recommended, because no studies had weighed the benefits of better detection against the costs of overdiagnosis[4].

The diagnosis itself comes from a clinical evaluation; the form states that an accurate diagnosis can only be made through a personal evaluation by a doctor[1]. The steps are covered in how bipolar disorder is diagnosed.

Frequently Asked Questions

Sources & References

  1. Oregon Health & Science University. Mood Disorder Questionnaire (MDQ). OHSU. Published 2019. Accessed October 2026. https://www.ohsu.edu/sites/default/files/2019-06/cms-quality-bipolar_disorder_mdq_screener.pdf [Link]
  2. Hirschfeld RMA, Williams JBW, Spitzer RL, et al. Development and Validation of a Screening Instrument for Bipolar Spectrum Disorder: The Mood Disorder Questionnaire. American Journal of Psychiatry. American Psychiatric Publishing. Published 2000. Accessed October 2026. https://psychiatryonline.org/doi/10.1176/appi.ajp.157.11.1873 [Link]
  3. Wang HR, Woo YS, Ahn HS, et al. The Validity of the Mood Disorder Questionnaire for Screening Bipolar Disorder: A Meta-Analysis. Depression and Anxiety. PubMed. Published 2015. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/26010478/ [Link]
  4. Zimmerman M, Galione JN. Screening for Bipolar Disorder With the Mood Disorders Questionnaire: A Review. Harvard Review of Psychiatry. PubMed. Published 2011. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/21916824/ [Link]
  5. Zimmerman M, Galione JN, Ruggero CJ, et al. Performance of the Mood Disorders Questionnaire in a Psychiatric Outpatient Setting. Bipolar Disorders. PubMed. Published 2009. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/19839999/ [Link]
  6. Wagner KD, Hirschfeld RM, Emslie GJ, et al. Validation of the Mood Disorder Questionnaire for Bipolar Disorders in Adolescents. Journal of Clinical Psychiatry. PubMed. Published 2006. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/16841633/ [Link]
  7. National Institute of Mental Health. Bipolar Disorder. National Institutes of Health. Published 2024. Accessed October 2026. https://www.nimh.nih.gov/health/topics/bipolar-disorder [Link]
  8. Weber Rouget B, Gervasoni N, Dubuis V, et al. Screening for Bipolar Disorders Using a French Version of the Mood Disorder Questionnaire (MDQ). Journal of Affective Disorders. PubMed. Published 2005. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/16054228/ [Link]
  9. Hirschfeld RMA, Cass AR, Holt DCL, Carlson CA. Screening for Bipolar Disorder in Patients Treated for Depression in a Family Medicine Clinic. Journal of the American Board of Family Practice. American Board of Family Medicine. Published 2005. Accessed October 2026. https://www.jabfm.org/content/18/4/233 [Link]
  10. Hirschfeld RMA, Holzer C, Calabrese JR, et al. Validity of the Mood Disorder Questionnaire: A General Population Study. American Journal of Psychiatry. American Psychiatric Publishing. Published 2003. Accessed October 2026. https://psychiatryonline.org/doi/10.1176/appi.ajp.160.1.178 [Link]
  11. Wang YY, Xu DD, Liu R, et al. Comparison of the Screening Ability Between the 32-Item Hypomania Checklist (HCL-32) and the Mood Disorder Questionnaire (MDQ) for Bipolar Disorder: A Meta-Analysis and Systematic Review. Psychiatry Research. PubMed. Published 2019. Accessed October 2026. https://pubmed.ncbi.nlm.nih.gov/30684793/ [Link]

Related Statistics